Chlorogenic Acid Ameliorates Post‐Infectious Irritable Bowel Syndrome by Regulating Extracellular Vesicles of Gut Microbes

Chlorogenic Acid Ameliorates Post‐Infectious Irritable Bowel Syndrome by Regulating Extracellular Vesicles of Gut Microbes

Abstract Post‐infectious irritable bowel syndrome (PI‐IBS) occurs after acute infectious diarrhea, and dysbiosis can be involved in its pathogenesis. Here, the role of chlorogenic acid (CGA) is investigated, a natural compound with several pharmacological properties, in alleviating PI‐IBS in rats. I...

Full description

Bibliographic Details
Main Authors:	Cihua Zheng, Yuchun Zhong, Wenming Zhang, Zhuoya Wang, Haili Xiao, Wenjun Zhang, Jian Xie, Xiaogang Peng, Jun Luo, Wei Xu
Format:	Article
Language:	English
Published:	Wiley 2023-10-01
Series:	Advanced Science
Subjects:	PI‐IBS bacteroides acidifaciens chlorogenic acid extracellular vesicles glycine
Online Access:	https://doi.org/10.1002/advs.202302798

Similar Items

Bacteroides acidifaciens and its derived extracellular vesicles improve DSS-induced colitis
by: Cihua Zheng, et al.
Published: (2023-11-01)

T-cell activation Rho GTPase-activating protein maintains intestinal homeostasis by regulating intestinal T helper cells differentiation through the gut microbiota
by: Ruirui He, et al.
Published: (2023-01-01)

Mucosal Microbiome Profiles Polygenic Irritable Bowel Syndrome in Mestizo Individuals
by: Rene Arredondo-Hernández, et al.
Published: (2020-03-01)

Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms
by: Annamaria Altomare, et al.
Published: (2021-04-01)

Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome
by: Yoshiyuki Mishima, et al.
Published: (2020-11-01)

The efficacy of vitamin D supplementation for irritable bowel syndrome: narrow scope and GRADE miss-interpretation
by: Mohamed Abuelazm, et al.
Published: (2023-01-01)

Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: A randomized controlled trial
by: Yaoliang Lai, et al.
Published: (2022-09-01)

Modern aspects of the treatment of irritable bowel syndrome
by: V. V. Tsukanov, et al.
Published: (2018-07-01)

Long-term probiotic administration for irritable bowel syndrome: a legal need
by: Olga I. Solovyeva, et al.
Published: (2023-10-01)

Diet and gut microbiome interactions of relevance for symptoms in irritable bowel syndrome
by: Julien Tap, et al.
Published: (2021-03-01)

Diagnosis of irritable bowel syndrome would be better made by gastroenterologists than primary care physicians
by: Mariette Bengtsson, et al.
Published: (2010-08-01)

Habitual FODMAP Intake in Relation to Symptom Severity and Pattern in Patients with Irritable Bowel Syndrome
by: Sanna Nybacka, et al.
Published: (2020-12-01)

Drug therapy’s new options in the treatment of the severe irritable bowel syndrome
by: Alina A. Makarova, et al.
Published: (2023-10-01)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
by: Özdener AE, et al.
Published: (2017-09-01)

The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome
by: Ashton Harper, et al.
Published: (2018-01-01)

Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management
by: Herekar A, et al.
Published: (2023-06-01)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
by: Xiufang Cui, et al.
Published: (2021-11-01)

Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management
by: Mónica Gros, et al.
Published: (2021-07-01)

Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome
by: Shengtao Zhu, et al.
Published: (2019-10-01)

Anxiety-depressive disorders among irritable bowel syndrome patients in Guilan, Iran
by: Modabbernia Mohamad-Jafar, et al.
Published: (2012-02-01)

Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives
by: Liu R, et al.
Published: (2020-04-01)

Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications
by: Maria Napolitano, et al.
Published: (2023-09-01)

Effects of Massa Medicata Fermentata on the intestinal pathogenic flagella bacteria and visceral hypersensitivity in rats with irritable bowel syndrome
by: Zhaomeng Zhuang, et al.
Published: (2022-11-01)

The use of peppermint oil in the treatment of irritable bowel syndrome
by: Karol Mazur, et al.
Published: (2020-06-01)

Use of Bismuth in Irritable Bowel Syndrome
by: T. A. Ilchishina
Published: (2021-10-01)

The role of inflammation in irritable bowel syndrome (IBS)
by: Ng QX, et al.
Published: (2018-09-01)

Irritable bowel syndrome: epidemiological and pathogenetic aspects
by: Tikhonova Т.А., et al.
Published: (2018-03-01)

Review of Pathophysiology and Diagnosis of Irritable Bowel Syndrome
by: Mohammad Reza Ghadir, et al.
Published: (2014-01-01)

Mineral water as non-medicamentous way in treatment of irritable bowel syndrome (IBS)
by: V. V. Skvortsov, et al.
Published: (2018-04-01)

Association Between Irritable Bowel Syndrome and Sleep Disturbance in Adolescents
by: Indah Kusumawati Noor L, et al.
Published: (2020-06-01)

Nutrition, Physical Activity and Supplementation in Irritable Bowel Syndrome
by: Marcelina Radziszewska, et al.
Published: (2023-08-01)

Efficacy of probiotics in irritable bowel syndrome: A randomized, double blind placebo-controlled study
by: Md. Zahidur Rahman, et al.
Published: (2016-08-01)

Role of diet and nutrition treatment methods in reducing the ailment of the irritable bowel syndrome
by: Radosław Jerzy Balwierz, et al.
Published: (2021-06-01)

Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms
by: Claudia Di Rosa, et al.
Published: (2023-03-01)

A Review of the Complex Relationship between Irritable Bowel Syndrome and Infertility
by: Carmen Anton, et al.
Published: (2020-11-01)

Modulation of the microbiota across different intestinal segments by Rifaximin in PI-IBS mice
by: Shengyan Zhang, et al.
Published: (2023-01-01)

Effects of Intestinal Flora on Irritable Bowel Syndrome and Therapeutic Significance of Polysaccharides
by: Yang Ye, et al.
Published: (2022-05-01)

Potato By-Products as a Source of Natural Chlorogenic Acids and Phenolic Compounds: Extraction, Characterization, and Antioxidant Capacity
by: Nicolas Joly, et al.
Published: (2020-12-01)

Epigenetic Mechanisms in Irritable Bowel Syndrome
by: Swapna Mahurkar-Joshi, et al.
Published: (2020-08-01)

The Role of Brain-Derived Neurotrophic Factor in Irritable Bowel Syndrome
by: Thomas Jan Konturek, et al.
Published: (2021-01-01)